Freedom Capital Markets Maintains Buy on Veracyte, Lowers Price Target to $40
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice Target
Freedom Capital Markets analyst Keith Hinton maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $66 to $40.
Freedom Capital Markets analyst Keith Hinton maintains Veracyte (NASDAQ:VCYT) with a Buy and lowers the price target from $66 to $40.